AstraZeneca PLC Ordinary Shares (AZN)
SG&A Expense Growth
14.52%
Quarterly · Period ending:
AZN SG&A Expense Growth
Latest reported14.52%period ending
Latest reported14.52%period ending
AZN Quarterly SG&A Growth (QoQ) (0.00% → 14.52%)
Latest values, visible window
High-resolution chart · PNG
AZN sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 14.5228% | |
| -10.3454% | |
| 7.8731% | |
| 4.5137% | |
| 8.2127% | |
| -16.6757% | |
| 5.0113% | |
| 4.4853% | |
| 9.3089% | |
| -16.0624% | |
| 11.9091% | |
| -3.674% | |
| 22.0367% | |
| -49.567% | |
| 88.8258% | |
| -8.4615% | |
| -3.1219% | |
| -34.0375% | |
| 78.7886% | |
| 31.5214% | |
| 5.7133% | |
| -40.4172% | |
| 79.6394% | |
| 3.2859% | |
| -2.3877% | |
| -14.0582% | |
| -0.6693% | |
| 8.6971% | |
| 16.6667% | |
| -3.7505% | |
| 9.0283% | |
| -6.2619% | |
| 3.8219% | |
| -13.1714% | |
| 13.6028% | |
| 5.8848% | |
| 2.2297% | |
| 61.8108% | |
| -40.7422% | |
| -21.1263% | |
| 18.6934% | |
| -4.3007% | |
| 0.3263% | |
| -9.5738% | |
| 6.0501% | |
| -31.0642% | |
| 29.6055% | |
| 2.6794% | |
| 12.0443% | |
| -40.6449% | |
| 82.4303% | |
| -1.3364% | |
| 0.9249% | |
| -5.5677% | |
| 12.2091% | |
| 0.9897% | |
| -4.4147% | |
| -21.3577% | |
| 17.8663% | |
| -7.4087% | |
| 14.2195% | |
| -0.8049% | |
| -15.6482% | |
| 21.8676% | |
| -0.0787% | |
| -28.5714% | |
| 29.9708% | |
| -5.5901% | |
| 18.7705% | |
| -26.1725% | |
| 35.7847% | |
| -11.7796% | |
| 1.9586% | |
| -19.6794% | |
| 31.1405% | |
| 7.2204% | |
| 5.18% | |
| -16.7702% | |
| 25.5505% | |
| -4.8035% | |
| 8.2742% | |
| -19.0895% | |
| 27.1401% | |
| -7.7613% | |
| 11.0613% | |
| 6.303% | |
| -6.1164% | |
| -8.8395% | |
| 10.1348% | |
| 0.401% | |
| 7.7687% | |
| 12.6505% | |
| 7.5097% | |
| -15.6231% | |
| 25.6163% | |
| -5.1241% | |
| 7.4965% | |
| 0% | |
| -100% | |
| -1.1687% |